157 related articles for article (PubMed ID: 17272747)
41. Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.
Ding H; Hashem M; Triggle C
Eur J Pharmacol; 2007 Apr; 561(1-3):121-8. PubMed ID: 17292348
[TBL] [Abstract][Full Text] [Related]
42. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
[TBL] [Abstract][Full Text] [Related]
43. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor activity is a key determinant for the effect of estradiol on fatty streak deposit in hypercholesterolemic mice.
Gourdy P; Schambourg A; Filipe C; Douin-Echinard V; Garmy-Susini B; Calippe B; Tercé F; Bayard F; Arnal JF
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2214-21. PubMed ID: 17690314
[TBL] [Abstract][Full Text] [Related]
45. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
[TBL] [Abstract][Full Text] [Related]
46. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
Jacob S; Laury-Kleintop L; Lanza-Jacoby S
J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
[TBL] [Abstract][Full Text] [Related]
47. Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice.
Xiao HB; Yang ZC; Jia SJ; Li NS; Jiang DJ; Zhang XH; Guo R; Zhou Z; Deng HW; Li YJ
Life Sci; 2007 Jun; 81(1):1-7. PubMed ID: 17532008
[TBL] [Abstract][Full Text] [Related]
48. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.
Mor A; Planer D; Luboshits G; Afek A; Metzger S; Chajek-Shaul T; Keren G; George J
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):893-900. PubMed ID: 17272749
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease.
Moens AL; Kass DA
J Cardiovasc Pharmacol; 2007 Sep; 50(3):238-46. PubMed ID: 17878750
[TBL] [Abstract][Full Text] [Related]
50. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.
Norata GD; Marchesi P; Pulakazhi Venu VK; Pasqualini F; Anselmo A; Moalli F; Pizzitola I; Garlanda C; Mantovani A; Catapano AL
Circulation; 2009 Aug; 120(8):699-708. PubMed ID: 19667236
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
Zhang LN; Vincelette J; Cheng Y; Mehra U; Chen D; Anandan SK; Gless R; Webb HK; Wang YX
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1265-70. PubMed ID: 19667112
[TBL] [Abstract][Full Text] [Related]
52. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
53. Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice.
Afek A; Kogan E; Maysel-Auslender S; Mor A; Regev E; Rubinstein A; Keren G; George J
Microvasc Res; 2009 May; 77(3):364-9. PubMed ID: 19323972
[TBL] [Abstract][Full Text] [Related]
54. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice.
Foteinos G; Hu Y; Xiao Q; Metzler B; Xu Q
Circulation; 2008 Apr; 117(14):1856-63. PubMed ID: 18378610
[TBL] [Abstract][Full Text] [Related]
55. Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits.
Prasad K
J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):38-48. PubMed ID: 19246336
[TBL] [Abstract][Full Text] [Related]
56. Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice.
Ohsawa I; Nishimaki K; Yamagata K; Ishikawa M; Ohta S
Biochem Biophys Res Commun; 2008 Dec; 377(4):1195-8. PubMed ID: 18996093
[TBL] [Abstract][Full Text] [Related]
57. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
58. Systemic deficiency of the MAP kinase-activated protein kinase 2 reduces atherosclerosis in hypercholesterolemic mice.
Jagavelu K; Tietge UJ; Gaestel M; Drexler H; Schieffer B; Bavendiek U
Circ Res; 2007 Nov; 101(11):1104-12. PubMed ID: 17885219
[TBL] [Abstract][Full Text] [Related]
59. Folic acid reverses endothelial dysfunction induced by inhibition of tetrahydrobiopterin biosynthesis.
Moat SJ; Clarke ZL; Madhavan AK; Lewis MJ; Lang D
Eur J Pharmacol; 2006 Jan; 530(3):250-8. PubMed ID: 16387296
[TBL] [Abstract][Full Text] [Related]
60. Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency.
Bodary PF; Shen Y; Vargas FB; Bi X; Ostenso KA; Gu S; Shayman JA; Eitzman DT
Circulation; 2005 Feb; 111(5):629-32. PubMed ID: 15668341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
